Intra-aortic balloon pump-related thrombocytopenia: Its effects on in-hospital mortality in cardiogenic shock patients
Intra-aortic balloon pump-related thrombocytopenia: Its effects on in-hospital mortality in cardiogenic shock patients
Aim: The present study aimed to evaluate the potential role of intra-aortic balloon pump (IABP)-related thrombocytopenia in patientswith cardiogenic shock (CS) due to ST elevation myocardial infarction (STEMI) dien in hospital.Material and Methods: We retrospectively included 142 consecutive CS patients who were treated with IABP support from September2013 to March 2017 in a tertiary heart center. IABP-related thrombocytopenia was defined as a platelet count of
___
- 1. Thomaz PG, Moura LA Júnior, Muramoto G, et al. Intra-aortic
balloon pump in cardiogenic shock: state of the art. Rev Col
Bras Cir. 2017;44:102-6.
- 2. Parissis H, Soo A, Al-Alao B. Intra-aortic balloon pump:
literature review of risk factors related to complications
of the intra-aortic balloon pump. J Cardiothorac Surg
2011;6:147.
- 3. Jiang X, Zhu Z, Ye M, et al. Clinical application of intra-aortic
balloon pump in patients with cardiogenic shock during
the perioperative period of cardiac surgery. Exp Ther Med
2017;13:1741-8.
- 4. Roy SK, Howard EW, Panza JA, et al. Clinical implications of
thrombocytopenia among patients undergoing intra-aortic
balloon pump counterpulsation in the coronary care unit.
Clin Cardiol 2010;33:30-5.
- 5. Vonderheide RH, Thadhani R, Kuter DJ. Association of
thrombocytopenia with the use of intra-aortic balloon
pumps. Am J Med 1998;105:27-32.
- 6. Gore JM, Spencer FA, Gurfinkel EP, Thrombocytopenia in
patients with an acute coronary syndrome (from the Global
Registry of Acute Coronary Events [GRACE]). Am J Cardiol
2009;103:175-80.
- 7. Sheng Z, Zhao H, Yan H, et al. Intra-aortic balloon pumping
and thrombocytopenia in patients with acute coronary
syndrome : Incidence, risk factors, and prognosis. Herz
2018;43:555-64.
- 8. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition
of myocardial infarction. Eur Heart J 2012;33:2551-67.
- 9. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock.
Ann Intern Med 1999;131:47-59.
- 10. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical
experience with intra-aortic balloon pumping in cardiogenic
shock. JAMA 1968;203:113-8.
- 11. Bregman D, Nichols AB, Weiss MB, et al. Percutaneous intraaortic
balloon insertion. Am J Cardiol 1980;46:261-4.
- 12. Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA.
Thrombocytopenia in patients treated with heparin,
combination antiplatelet therapy, and intra-aortic balloon
pump counterpulsation. J Interv Cardiol 2008;21:350-6.
- 13. Venkata C, Kashyap R, Farmer JC, et al. Thrombocytopenia
in adult patients with sepsis: incidence, risk factors, and its
association with clinical outcome. J Intensive Care 2013;1:9.
- 14. Sinkovič A, Majal M. The Impact of Thrombocytopenia on
Outcome in Patients with Acute Coronary Syndromes:
A Single Center Retrospective Study. Biomed Res Int.
2015;2015:907304.